MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2024 International Congress

    Rapidly Progressive Pallidopyramidal Syndrome related to Parkin gene mutation

    F. Mustafa, A. Elavarasi, D. Vibha, R. Singh, J. Parihar, M. Tripathi, A. Das (Calicut, India)

    Objective: To describe a case of rapidly progressive Pallidopyramidal syndrome related to Parkin gene mutation. Background: Parkin gene mutations are most commonly found in autosomal…
  • 2024 International Congress

    Expanding Diversity of Parkinson’s Disease and Related Disorders Genetic Data: from the Global Parkinson’s Genetics Program

    G. Parkinson'S_genetics_program (gp2) (Bethesda, USA)

    Objective: To expand the research dataset for Parkinson’s Disease (PD) and related disorders by including >50,000 participants globally who have been genotyped or whole genome…
  • 2024 International Congress

    Characteristics of tremor frequency oscillatory neurons in the basal ganglia and thalamus in Parkinson’s tremor

    P. Zhuang, M. Meng, Y. Zhang, J. Li, J. Li, Y. Hu, M. Hallett, Y. Li (Beijing, China)

    Objective: To characterize tremor frequency oscillatory neurons in the basal ganglia and thalamus in patients with Parkinson’s tremor. Background: Evidence that the basal ganglia and…
  • 2024 International Congress

    Movement Disorders in Autoimmune Encephalitis: A case series of 11 cases.

    G. Costa, C. Del Prado, A. Marin, I. Apaza, M. Bendersky, C. Simison, P. Hernandez, F. Echeverria, T. Arakaki, S. Rodriguez Quiroga, N. Garretto (CABA Buenos Aires, Argentina)

    Objective: Describe abnormal movements associated with autoimmune encephalopathies (AIE) Background: Movement disorders are a hallmark feature of autoimmune encephalitis (AIE), playing a pivotal role in…
  • 2024 International Congress

    Diagnostic Spectrum in a Cohort of Atypical Atypical Parkinsonism

    P. Katragadda, V. Holla, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

    Objective: To retrospectively look at atypical Parkinsonism mimics in our cohort and reappraise the clinical features of these subset of patients Background: Atypical parkinsonism syndromes…
  • 2024 International Congress

    Quantitative Assessment of X-linked Dystonia-Parkinsonism Using Wearable Sensing Technology

    G. Corniani, G. Del Duca, S. Sanseverino, N. Ganza, S. Begalan, C. Nelson, P. Acuna, C. Go, N. Sharma, P. Bonato, C. Stephen (Boston, USA)

    Objective: To create a quantitative, objective framework for assessing combined dystonia parkinsonism using kinematic data from wearable sensors combined with machine learning (ML), enabling clinician-independent…
  • 2024 International Congress

    Impact of Striatal Degeneration on Clinical Phenotype in Idiopathic Normal Pressure Hydrocephalus: A Comparative Analysis

    K. Badiola-Lim, Q. Hu, N. Prakash (Summit, USA)

    Objective: To compare the clinical phenotype between patients with normal and abnormal dopamine transporter scan (DaTscan) in probable and definite idiopathic normal pressure hydrocephalus (iNPH).…
  • 2024 International Congress

    Managing Cognitive Decline in Vascular Dementia with Associated Parkinsonism

    J. Hall, R. Islam, C. Rowan, B. Carr (GAINESVILLE, USA)

    Objective: The intersection of vascular dementia (VaD) and secondary parkinsonism presents a complex therapeutic conundrum, particularly in geriatric populations. This study aims to elucidate the…
  • 2024 International Congress

    Abstract: Trends in Movement Disorders related death in the United States from 1999 to 2020

    A. Khalid, L. Munir, A. Chaudhary, M. Ammar-Ur-Rahman, A. Alabedi (Lahore, Pakistan)

    Objective: We aimed to analyze the mortality and prevalence of movement disorders in the United States from 1999 to 2020 to compare disparities among various…
  • 2024 International Congress

    Effects of ectopic dopamine D2 autoregulation of raphe-striatal projecting neurons on established L-DOPA-mediated behaviors in a hemiparkinsonian rat model

    A. Centner, N. Lipari, C. Budrow, G. Mcmanus, I. Sandoval, K. Tseng, F. Manfredsson, C. Bishop (Binghamton, USA)

    Objective: Levodopa (LD) is the standard treatment for Parkinson’s Disease (PD) despite risk of LD-induced dyskinesia (LID) development within a decade of treatment. Serotonergic (5-HT)…
  • « Previous Page
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley